TREM1 and familial pancreatic carcinoma: We further demonstrated that these LPC can therapeutically inhibit TREM-1 in various inflammatory diseases, including CIA [30], pancreatic cancer [76], retinopathy of prematurity [77], and alcoholic liver disease [78].